HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
LLY
Lilly(Eli) & Company
Healthcare Drug Manufacturers - General · Indiana, USA · Reports in usd
Market Cap: $908.76B
Market Cap
$908.76B
Enterprise Val
$946.85B
P/E Ratio
35.95
P/B Ratio
29.13
Trailing PEG (1Y)
0.21
As Of
Apr 30, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$31.20B
Gross Margin81.93%
Profit Margin81.93%
Return on Equity101.31%
Return on Assets22.73%
Current Ratio1.50
Debt/Equity1.39
LT Debt/Equity1.26
Revenue Per Share20.99

Income Statement

Mar 31, 2026
Revenue$19.80B
Cost of Revenue$3.58B
Gross Profit$16.22B
R&D$3.51B
SG&A$2.93B
Operating Expenses$7.31B
Operating Income$8.92B
Interest Expense$0.00
Tax Expense$1.45B
Net Income$7.40B
EPS (Basic)$8.27
EPS (Diluted)$8.26
EBIT$8.85B
EBITDA$9.36B
Consolidated Income$7.40B
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$5.28B
Accounts Receivable$21.18B
Inventory$14.53B
Current Assets$54.84B
LT Investments$3.12B
Property, Plant & Equipment$26.54B
Intangibles$13.50B
Non-Current Assets$61.74B
Total Assets$116.58B
Accounts Payable$5.03B
Current Debt$4.00B
Current Liabilities$36.63B
LT Debt$39.37B
Non-Current Liabilities$48.74B
Total Liabilities$85.38B
Total Debt$43.37B
Retained Earnings$29.51B
Shareholder Equity$31.20B
Shares Outstanding943,357,420

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$5.33B
Investing Cash Flow-$3.92B
Financing Cash Flow-$3.47B
CapEx-$2.33B
Free Cash Flow$3.01B
Depreciation & Amort.$509.0M
Stock-Based Comp$161.0M
Acquisitions / Disposals-$1.06B
Investment Activity-$297.0M
Debt Issued/Repaid$1.03B
Equity Issued/Repaid-$2.36B
Dividends Paid-$1.55B
Net Change in Cash-$1.99B
Data cached · Meta live · Daily live · Statements live · TTL 24h